期刊文献+

国产异环磷酰胺、顺铂和长春酰胺联合用药治疗晚期肺癌 被引量:7

Combined Chemotherapy of Advanced Lung Cancer withHome Made IFO, DDP and VDS
暂未订购
导出
摘要 探讨国产异环磷酰胺为主的联合化疗方案治疗晚期肺癌的疗效及毒副作用。方法:43例肺癌中非小细胞肺癌40例,其中Ⅲ期2例、Ⅳ期38例;小细胞肺癌3例。化疗方案为异环磷酰胺2.0g静滴,顺铂30mg静注,连用3天,长春酰胺4mg第1天静注,用尿路保护剂琉乙黄酸钠400mg于异环磷酰胺后0、4、8h输注,每周期间隔21~28天,均应用2个周期以上。结果:总缓解率44.1%(19/43),初治者45%(14/31),再次化疗者41.6%(5/12),中位缓解期8个月,1年生存率为32%。主要毒副作用为骨髓抑制。结论:以国产异环磷酰胺为主联合化疗方案对晚期肺癌有较好的疗效和可耐受的毒副作用。 Purpose: To evaluate the therapeutic effect and side - effects of combined chemothera-py of advanced lung cancer with home made agents. Methods: In a total of 43 cases of advanced lung can-cer (NSCLC 40, SCLC 3 ), chemotherapy consisting of IFO 2. 0 gtt, DDP 30mg iv qd for three days,VDS 4mg iv on the first day and Mesna 400mg iv at 0, 4, 8 hours after the administration of IFO. Twotherapeutic courses were given with an interval of 21 to 28 days. Results: Overall PR was 44. 1% ( 19/43 ) being 45% ( 14/31 ) and 41. 6% (5/ 12) for primary and secondary cases respectively. The meanrelief interval was 8 months and 1 - year survival rate was 32% . The main side - effect was myelosuppres-sion. Conclusion: It is thought that the combined chemotherapy with domestic IFO, DDP and VDS gavejust as good effect for advanced lung cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1999年第3期204-206,共3页 Chinese Journal of Clinical Oncology
关键词 异环磷酰胺 肺肿瘤 顺铂 长春酰胺 IFO,Advanced lung carcinoma,Combined chemotherapy
  • 相关文献

参考文献7

二级参考文献2

共引文献25

同被引文献14

引证文献7

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部